immatics biotechnologies GmbH (IMTXW) — Financial Flexibility Index
immatics biotechnologies GmbH (IMTXW) has a Financial Flexibility Index of -0.30x as of March 2025. Free cash flow of $-31.07 Million (operating CF $-34.21 Million minus capex $3.13 Million) represents 0% of total liabilities ($105.09 Million). Check immatics biotechnologies GmbH investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
immatics biotechnologies GmbH Financial Flexibility Index (2018–2024)
Historical Financial Flexibility Index trend for immatics biotechnologies GmbH across 7 annual periods. For the full cash flow conversion analysis, see immatics biotechnologies GmbH (IMTXW) cash conversion ratio.
Annual Financial Flexibility Index for immatics biotechnologies GmbH (2018–2024)
Year-by-year free cash flow to debt coverage for immatics biotechnologies GmbH. Explore IMTXW cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.17x | $-141.55 Million | $-158.03 Million | $121.30 Million | ▼ -775.9% |
| 2023 | 0.17x | $49.19 Million | $18.23 Million | $284.88 Million | ▼ -68.4% |
| 2022 | 0.55x | $106.35 Million | $100.13 Million | $194.66 Million | ▲ +208.1% |
| 2021 | -0.51x | $-76.13 Million | $-81.78 Million | $150.58 Million | ▲ +2.6% |
| 2020 | -0.52x | $-78.09 Million | $-85.61 Million | $150.39 Million | ▼ -224.2% |
| 2019 | 0.42x | $73.20 Million | $70.97 Million | $175.11 Million | ▲ +39.1% |
| 2018 | 0.30x | $21.19 Million | $20.68 Million | $70.49 Million | — |